SIX FinanciaI Information and Numerix partner for OTC Derivative Valuations
Posted: 12 November 2012 | Source: SIX Financial Information
SIX Financial Information and Numerix announce that they have signed a strategic partnership agreement to produce valuations for OTC derivatives.
SIX Financial Information, a premium provider of global financial information, is partnering with Numerix, a leading provider of cross-asset analytics for derivatives valuations and risk management, to produce valuations for a wide range of vanilla and OTC derivative instruments as part of the Evaluated Pricing Service (EPS). The new service complements SIX Financial Information’s proprietary pricing for fixed income products by expanding client’s options to value a wider range of their portfolio in a consistent and reliable manner.
“We are delighted to have agreed this partnership with Numerix,” said Bruno Burlon, Global Head of Evaluated Pricing for SIX Financial Information. “Working with a proven, industry leading analytics provider allows us to broaden our asset class coverage in a high quality and credible way.”
“We are excited to welcome SIX Financial Information into the Numerix Partner Program,” said Steven R. O’Hanlon, President & Chief Operating Officer of Numerix. “Clients of SIX Financial Information’s pricing service will benefit from the most comprehensive instrument coverage in the industry as well as our powerful analytics platform and cross-asset library of market-tested models for pricing complex structured products and derivatives.”
The partnership involves SIX Financial Information deploying Numerix analytics in its EPS infrastructure to broaden and enhance coverage of OTC derivative instruments. The first phase of the partnership has already been developed and includes Interest Rate Swaps and Credit Default Swaps. Additional asset classes will be added to the service incrementally over the coming months.
Ian Blance, Head of Evaluated Pricing Business Development for SIX Financial Information states, “Our clients require reliable and defensible valuations for a broad range of financial instruments where market pricing is either unavailable or inconsistent. By adding the capability for OTC derivative valuations to our strong fixed income product we are broadening the solution we can offer to clients in this area, and increasing our ability to assist them in meeting their commitment to independent and objective pricing.”